Back to mobile site

Medicis (MRX) Shares Showing Resilience Despite FDA Letter for LIPOSONIX

July 7, 2010 1:12 PM EDT Send to a Friend
Shares of Medicis (NYSE: MRX) are making their way back up towards positive territory, despite the recent letter from the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login